We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Integra Gets Form 483 After Audit Reveals CAPA, GMP Deviations
Integra Gets Form 483 After Audit Reveals CAPA, GMP Deviations
January 3, 2013
Plainsboro, N.J.-based Integra Lifesciences landed a seven-observation Form 483 detailing problems found with the company’s corrective and prevention action (CAPA) procedures and GMP violations.